{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T10:36:29Z","timestamp":1773225389234,"version":"3.50.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T00:00:00Z","timestamp":1770422400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T00:00:00Z","timestamp":1773100800000},"content-version":"vor","delay-in-days":31,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Cell Int"],"DOI":"10.1186\/s12935-026-04199-1","type":"journal-article","created":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T16:34:31Z","timestamp":1770482071000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Potential correlation between high SNHG expression and poor pancreatic cancer prognosis: evidence from systematic reviews and meta-analyses"],"prefix":"10.1186","volume":"26","author":[{"given":"Sheng-qi","family":"Du","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ya-Tong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,7]]},"reference":[{"issue":"1","key":"4199_CR1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.21763","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. Cancer J Clin. 2023;73(1):17\u201348.","journal-title":"Cancer J Clin"},{"issue":"10","key":"4199_CR2","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.1002\/cncr.32802","volume":"126","author":"SJ Henley","year":"2020","unstructured":"Henley SJ, Ward EM, Scott S, Ma J, Anderson RN, Firth AU, Thomas CC, Islami F, Weir HK, Lewis DR, et al. Annual report to the Nation on the status of cancer, part I: National cancer statistics. Cancer. 2020;126(10):2225\u201349.","journal-title":"Cancer"},{"key":"4199_CR3","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.cancergen.2024.06.002","volume":"286\u2013287","author":"D Sonkin","year":"2024","unstructured":"Sonkin D, Thomas A, Teicher BA. Cancer treatments: Past, present, and future. Cancer Genet. 2024;286\u2013287:18\u201324.","journal-title":"Cancer Genet"},{"issue":"3","key":"4199_CR4","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"Cancer J Clin"},{"issue":"1","key":"4199_CR5","first-page":"16","volume":"25","author":"LA Torre","year":"2016","unstructured":"Torre LA, Siegel RL, Ward EM, Jemal A. Global cancer incidence and mortality rates and Trends\u2013An Update. Cancer epidemiology, biomarkers & prevention: a publication of the American association for cancer research. Cosponsored Am Soc Prev Oncol. 2016;25(1):16\u201327.","journal-title":"Cosponsored Am Soc Prev Oncol"},{"issue":"2","key":"4199_CR6","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1053\/j.gastro.2022.03.056","volume":"163","author":"LD Wood","year":"2022","unstructured":"Wood LD, Canto MI, Jaffee EM, Simeone DM. Pancreatic cancer: Pathogenesis, Screening, Diagnosis, and treatment. Gastroenterology. 2022;163(2):386\u2013e402381.","journal-title":"Gastroenterology"},{"issue":"4","key":"4199_CR7","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1007\/s00535-013-0915-x","volume":"49","author":"S Hamada","year":"2014","unstructured":"Hamada S, Masamune A, Shimosegawa T. Inflammation and pancreatic cancer: disease promoter and new therapeutic target. J Gastroenterol. 2014;49(4):605\u201317.","journal-title":"J Gastroenterol"},{"issue":"9","key":"4199_CR8","doi-asserted-by":"publisher","first-page":"2335","DOI":"10.3748\/wjg.v20.i9.2335","volume":"20","author":"H Onishi","year":"2014","unstructured":"Onishi H, Katano M. Hedgehog signaling pathway as a new therapeutic target in pancreatic cancer. World J Gastroenterol. 2014;20(9):2335\u201342.","journal-title":"World J Gastroenterol"},{"issue":"7963","key":"4199_CR9","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/s41586-023-06063-y","volume":"618","author":"LA Rojas","year":"2023","unstructured":"Rojas LA, Sethna Z, Soares KC, Olcese C, Pang N, Patterson E, Lihm J, Ceglia N, Guasp P, Chu A, et al. Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer. Nature. 2023;618(7963):144\u201350.","journal-title":"Nature"},{"issue":"4","key":"4199_CR10","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1002\/path.5926","volume":"257","author":"S Menezes","year":"2022","unstructured":"Menezes S, Okail MH, Jalil SMA, Kocher HM, Cameron AJM. Cancer-associated fibroblasts in pancreatic cancer: new subtypes, new markers, new targets. J Pathol. 2022;257(4):526\u201344.","journal-title":"J Pathol"},{"issue":"1","key":"4199_CR11","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1186\/s13045-021-01149-4","volume":"14","author":"M Reese","year":"2021","unstructured":"Reese M, Dhayat SA. Small extracellular vesicle non-coding RNAs in pancreatic cancer: molecular mechanisms and clinical implications. J Hematol Oncol. 2021;14(1):141.","journal-title":"J Hematol Oncol"},{"key":"4199_CR12","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.canlet.2020.12.005","volume":"501","author":"EE Robless","year":"2021","unstructured":"Robless EE, Howard JA, Casari I, Falasca M. Exosomal long non-coding RNAs in the diagnosis and oncogenesis of pancreatic cancer. Cancer Lett. 2021;501:55\u201365.","journal-title":"Cancer Lett"},{"issue":"4","key":"4199_CR13","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1152\/physrev.00041.2015","volume":"96","author":"J Beermann","year":"2016","unstructured":"Beermann J, Piccoli MT, Viereck J, Thum T. Non-coding RNAs in development and disease: Background, Mechanisms, and therapeutic approaches. Physiol Rev. 2016;96(4):1297\u2013325.","journal-title":"Physiol Rev"},{"issue":"4","key":"4199_CR14","doi-asserted-by":"publisher","first-page":"e12457","DOI":"10.1111\/cpr.12457","volume":"51","author":"X Yu","year":"2018","unstructured":"Yu X, Zheng H, Tse G, Chan MT, Wu WK. Long non-coding RNAs in melanoma. Cell Prolif. 2018;51(4):e12457.","journal-title":"Cell Prolif"},{"key":"4199_CR15","doi-asserted-by":"publisher","first-page":"144298","DOI":"10.1016\/j.gene.2019.144298","volume":"729","author":"A Bagchi","year":"2020","unstructured":"Bagchi A. Unusual nature of long non-coding RNAs coding for unusual peptides. Gene. 2020;729:144298.","journal-title":"Gene"},{"issue":"35","key":"4199_CR16","doi-asserted-by":"publisher","first-page":"57379","DOI":"10.18632\/oncotarget.10545","volume":"7","author":"X Huang","year":"2016","unstructured":"Huang X, Zhi X, Gao Y, Ta N, Jiang H, Zheng J. LncRNAs in pancreatic cancer. Oncotarget. 2016;7(35):57379\u201390.","journal-title":"Oncotarget"},{"key":"4199_CR17","doi-asserted-by":"crossref","unstructured":"Li J, Hou S, Ye Z, Wang W, Hu X, Hang Q. Long Non-Coding RNAs in pancreatic cancer: biologic Functions, Mechanisms, and clinical significance. Cancers 2022, 14(9).","DOI":"10.3390\/cancers14092115"},{"key":"4199_CR18","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1186\/s12935-020-01550-y","volume":"20","author":"Y Wang","year":"2020","unstructured":"Wang Y, Zhou L, Lu J, Jiang B, Liu C, Guo J, Xiao GG. Research progress on long non-coding RNAs and their roles as potential biomarkers for diagnosis and prognosis in pancreatic cancer. Cancer Cell Int. 2020;20:457.","journal-title":"Cancer Cell Int"},{"key":"4199_CR19","doi-asserted-by":"publisher","first-page":"748442","DOI":"10.3389\/fcell.2021.748442","volume":"9","author":"X Yu","year":"2021","unstructured":"Yu X, Dong P, Yan Y, Liu F, Wang H, Lv Y, Song M, Yao Q, Hu S. Identification of N6-Methyladenosine-Associated long Non-coding RNAs for immunotherapeutic response and prognosis in patients with pancreatic cancer. Front Cell Dev Biology. 2021;9:748442.","journal-title":"Front Cell Dev Biology"},{"issue":"7","key":"4199_CR20","doi-asserted-by":"publisher","first-page":"3654","DOI":"10.1111\/jcmm.16425","volume":"25","author":"H Miao","year":"2021","unstructured":"Miao H, Lu J, Guo Y, Qiu H, Zhang Y, Yao X, Li X, Lu Y. LncRNA TP73-AS1 enhances the malignant properties of pancreatic ductal adenocarcinoma by increasing MMP14 expression through MiRNA \u2013\u2009200a sponging. J Cell Mol Med. 2021;25(7):3654\u201364.","journal-title":"J Cell Mol Med"},{"issue":"9","key":"4199_CR21","doi-asserted-by":"publisher","first-page":"2572","DOI":"10.7150\/jca.37959","volume":"11","author":"J Sun","year":"2020","unstructured":"Sun J, Zhang P, Yin T, Zhang F, Wang W. Upregulation of LncRNA PVT1 facilitates pancreatic ductal adenocarcinoma cell progression and Glycolysis by regulating MiR-519d-3p and HIF-1A. J Cancer. 2020;11(9):2572\u20139.","journal-title":"J Cancer"},{"key":"4199_CR22","doi-asserted-by":"publisher","first-page":"986615","DOI":"10.3389\/fimmu.2022.986615","volume":"13","author":"Y Fan","year":"2022","unstructured":"Fan Y, Gao Z, Xu J, Wang H, Guo Q, Xue H, Zhao R, Guo X, Li G. Identification and validation of SNHG gene signature to predict malignant behaviors and therapeutic responses in glioblastoma. Front Immunol. 2022;13:986615.","journal-title":"Front Immunol"},{"key":"4199_CR23","doi-asserted-by":"crossref","unstructured":"Tan AQ, Zheng YF. The roles of SNHG family in osteoblast differentiation. Genes 2022, 13(12).","DOI":"10.3390\/genes13122268"},{"key":"4199_CR24","doi-asserted-by":"publisher","first-page":"813850","DOI":"10.3389\/fonc.2022.813850","volume":"12","author":"S Chen","year":"2022","unstructured":"Chen S, Guo W, Meng M, Wu D, Zhou T, Wang L, Xu J. LncRNA SNHG1 promotes the progression of pancreatic cancer by regulating FGFR1 expression via competitively binding to miR-497. Front Oncol. 2022;12:813850.","journal-title":"Front Oncol"},{"key":"4199_CR25","doi-asserted-by":"crossref","unstructured":"Gao G, Li X, Wu H, Huang LL, Lin YX, Huo Z, Xiang ZY, Zhou X. LncRNA SNHG6 upregulates KPNA5 to overcome gemcitabine resistance in pancreatic cancer via sponging miR-944. Pharmaceuticals (Basel Switzerland) 2023, 16(2).","DOI":"10.3390\/ph16020184"},{"issue":"5","key":"4199_CR26","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.3892\/etm.2021.10708","volume":"22","author":"P Jiang","year":"2021","unstructured":"Jiang P, Yin Y, Wu Y, Sun Z. Silencing of long non-coding RNA SNHG15 suppresses proliferation, migration and invasion of pancreatic cancer cells by regulating the microRNA-345-5p\/RAB27B axis. Experimental Therapeutic Med. 2021;22(5):1273.","journal-title":"Experimental Therapeutic Med"},{"issue":"23","key":"4199_CR27","first-page":"8161","volume":"22","author":"Y Song","year":"2018","unstructured":"Song Y, Zou L, Li J, Shen ZP, Cai YL, Wu XD. LncRNA SNHG8 promotes the development and chemo-resistance of pancreatic adenocarcinoma. Eur Rev Med Pharmacol Sci. 2018;22(23):8161\u20138.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"4","key":"4199_CR28","doi-asserted-by":"publisher","first-page":"398","DOI":"10.3892\/etm.2021.9829","volume":"21","author":"Y Jian","year":"2021","unstructured":"Jian Y, Fan Q. Long non-coding RNA SNHG7 facilitates pancreatic cancer progression by regulating the miR-146b-5p\/Robo1 axis. Experimental Therapeutic Med. 2021;21(4):398.","journal-title":"Experimental Therapeutic Med"},{"issue":"8","key":"4199_CR29","first-page":"2648","volume":"10","author":"B Zhang","year":"2018","unstructured":"Zhang B, Li C, Sun Z. Long non-coding RNA LINC00346, LINC00578, LINC00673, LINC00671, LINC00261, and SNHG9 are novel prognostic markers for pancreatic cancer. Am J Translational Res. 2018;10(8):2648\u201358.","journal-title":"Am J Translational Res"},{"key":"4199_CR30","first-page":"n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ (Clinical Res ed). 2021;372:n71.","journal-title":"BMJ (Clinical Res ed)"},{"issue":"9","key":"4199_CR31","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","volume":"25","author":"A Stang","year":"2010","unstructured":"Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9):603\u20135.","journal-title":"Eur J Epidemiol"},{"key":"4199_CR32","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1745-6215-8-16","volume":"8","author":"JF Tierney","year":"2007","unstructured":"Tierney JF, Stewart LA, Ghersi D, Burdett S, Sydes MR. Practical methods for incorporating summary time-to-event data into meta-analysis. Trials. 2007;8:16.","journal-title":"Trials"},{"key":"4199_CR33","doi-asserted-by":"publisher","first-page":"4969","DOI":"10.2147\/CMAR.S312469","volume":"13","author":"S Cao","year":"2021","unstructured":"Cao S, Li H, Li L. LncRNA SNHG17 contributes to the progression of cervical cancer by targeting microRNA-375-3p. Cancer Manage Res. 2021;13:4969\u201378.","journal-title":"Cancer Manage Res"},{"key":"4199_CR34","doi-asserted-by":"publisher","first-page":"7955","DOI":"10.2147\/OTT.S167065","volume":"11","author":"L Chen","year":"2018","unstructured":"Chen L, Liu J, Tang T, Zhang YC, Liu MZ, Xu LY, Zhang J. LncRNA differentiation antagonizing nonprotein coding RNA overexpression accelerates progression and indicates poor prognosis in pancreatic ductal adenocarcinoma. OncoTargets Therapy. 2018;11:7955\u201365.","journal-title":"OncoTargets Therapy"},{"key":"4199_CR35","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s13578-019-0290-2","volume":"9","author":"D Cheng","year":"2019","unstructured":"Cheng D, Fan J, Ma Y, Zhou Y, Qin K, Shi M, Yang J. LncRNA SNHG7 promotes pancreatic cancer proliferation through ID4 by sponging miR-342-3p. Cell Bioscience. 2019;9:28.","journal-title":"Cell Bioscience"},{"issue":"11","key":"4199_CR36","doi-asserted-by":"publisher","first-page":"7222","DOI":"10.1111\/jcmm.14467","volume":"23","author":"PC Deng","year":"2019","unstructured":"Deng PC, Chen WB, Cai HH, An Y, Wu XQ, Chen XM, Sun DL, Yang Y, Shi LQ, Yang Y. LncRNA SNHG14 potentiates pancreatic cancer progression via modulation of Annexin A2 expression by acting as a competing endogenous RNA for miR-613. J Cell Mol Med. 2019;23(11):7222\u201332.","journal-title":"J Cell Mol Med"},{"issue":"18","key":"4199_CR37","first-page":"5892","volume":"22","author":"XB Guo","year":"2018","unstructured":"Guo XB, Yin HS, Wang JY. Evaluating the diagnostic and prognostic value of long non-coding RNA SNHG15 in pancreatic ductal adenocarcinoma. Eur Rev Med Pharmacol Sci. 2018;22(18):5892\u20138.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"3","key":"4199_CR38","first-page":"730","volume":"12","author":"D Li","year":"2019","unstructured":"Li D, Zhang X, Yang Y, Shen Y, Zhang Q, Liu H, Li X, Zhang C, Liu P, Qin X. Long non-coding RNA SNHG1 promotes Cyclin D1-mediated proliferation in pancreatic cancer by acting as a CeRNA of miR-195. Int J Clin Exp Pathol. 2019;12(3):730\u20139.","journal-title":"Int J Clin Exp Pathol"},{"key":"4199_CR39","doi-asserted-by":"publisher","first-page":"108862","DOI":"10.1016\/j.biopha.2019.108862","volume":"114","author":"S Liu","year":"2019","unstructured":"Liu S, Zhang W, Liu K, Liu Y. LncRNA SNHG16 promotes tumor growth of pancreatic cancer by targeting miR-218-5p. Biomed pharmacotherapy = Biomedecine Pharmacotherapie. 2019;114:108862.","journal-title":"Biomed pharmacotherapy = Biomedecine Pharmacotherapie"},{"issue":"48","key":"4199_CR40","doi-asserted-by":"publisher","first-page":"84153","DOI":"10.18632\/oncotarget.20359","volume":"8","author":"Z Ma","year":"2017","unstructured":"Ma Z, Huang H, Wang J, Zhou Y, Pu F, Zhao Q, Peng P, Hui B, Ji H, Wang K. Long non-coding RNA SNHG15 inhibits P15 and KLF2 expression to promote pancreatic cancer proliferation through EZH2-mediated H3K27me3. Oncotarget. 2017;8(48):84153\u201367.","journal-title":"Oncotarget"},{"issue":"3","key":"4199_CR41","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1007\/s10637-019-00798-0","volume":"38","author":"Y Tang","year":"2020","unstructured":"Tang Y, Cao G, Zhao G, Wang C, Qin Q. LncRNA differentiation antagonizing non-protein coding RNA promotes proliferation and invasion through regulating miR-135a\/NLRP37 axis in pancreatic cancer. Investig New Drugs. 2020;38(3):714\u201321.","journal-title":"Investig New Drugs"},{"issue":"3","key":"4199_CR42","doi-asserted-by":"publisher","first-page":"357","DOI":"10.3233\/CBM-190908","volume":"27","author":"F Xie","year":"2020","unstructured":"Xie F, Huang Q, Wang C, Chen S, Liu C, Lin X, Lv X, Wang C. Downregulation of long noncoding RNA SNHG14 suppresses cell proliferation and invasion by regulating EZH2 in pancreatic ductal adenocarcinoma (PDAC). Cancer Biomark A. 2020;27(3):357\u201364.","journal-title":"Cancer Biomark A"},{"issue":"1","key":"4199_CR43","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s12935-020-01715-9","volume":"21","author":"H Xu","year":"2021","unstructured":"Xu H, Miao X, Li X, Chen H, Zhang B, Zhou W. LncRNA SNHG16 contributes to tumor progression via the miR-302b-3p\/SLC2A4 axis in pancreatic adenocarcinoma. Cancer Cell Int. 2021;21(1):51.","journal-title":"Cancer Cell Int"},{"key":"4199_CR44","doi-asserted-by":"publisher","first-page":"4544","DOI":"10.12659\/MSM.916960","volume":"25","author":"Z Yao","year":"2019","unstructured":"Yao Z, Chen Q, Ni Z, Zhou L, Wang Y, Yang Y, Huang H. Long Non-Coding RNA differentiation antagonizing nonprotein coding RNA (DANCR) promotes proliferation and invasion of pancreatic cancer by sponging miR-214-5p to regulate E2F2 expression. Med Sci Monitor: Int Med J Experimental Clin Res. 2019;25:4544\u201352.","journal-title":"Med Sci Monitor: Int Med J Experimental Clin Res"},{"issue":"15","key":"4199_CR45","doi-asserted-by":"publisher","first-page":"2713","DOI":"10.7150\/jca.26207","volume":"9","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, Zhang R, Luo G, Ai K. Long noncoding RNA SNHG1 promotes cell proliferation through PI3K\/AKT signaling pathway in pancreatic ductal adenocarcinoma. J Cancer. 2018;9(15):2713\u201322.","journal-title":"J Cancer"},{"key":"4199_CR46","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.cancergen.2024.05.001","volume":"284\u2013285","author":"J Liu","year":"2024","unstructured":"Liu J, Zhang Y, Wu J, Liu X, Li L, Zhang J. LncRNA FOXD2-AS1 promotes the growth, invasion and migration of OSCC cells by regulating the MiR-185-5p\/PLOD1\/Akt\/mTOR pathway. Cancer Genet. 2024;284\u2013285:48\u201357.","journal-title":"Cancer Genet"},{"key":"4199_CR47","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.cancergen.2023.12.006","volume":"282\u2013283","author":"A Ghorbani","year":"2024","unstructured":"Ghorbani A, Hosseinie F, Khorshid Sokhangouy S, Islampanah M, Khojasteh-Leylakoohi F, Maftooh M, Nassiri M, Hassanian SM, Ghayour-Mobarhan M, Ferns GA, et al. The prognostic, diagnostic, and therapeutic impact of long noncoding RNAs in gastric cancer. Cancer Genet. 2024;282\u2013283:14\u201326.","journal-title":"Cancer Genet"},{"key":"4199_CR48","doi-asserted-by":"crossref","unstructured":"Encarnao CC, Faria GM, Franco VA, Botelho LGX, Moraes JA. Renovato-Martins MJJoCM, treatment: interconnections within the tumor microenvironment: extracellular vesicles as critical players of metabolic reprogramming in tumor cells. 2024.","DOI":"10.20517\/2394-4722.2024.78"},{"key":"4199_CR49","doi-asserted-by":"crossref","unstructured":"Liu H, Yang Z. Time management and personal efficiency in the age of computational and systems oncology. 2024, 4(1):e70001.","DOI":"10.1002\/cso2.70001"}],"container-title":["Cancer Cell International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12935-026-04199-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-026-04199-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-026-04199-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T14:04:00Z","timestamp":1773151440000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12935-026-04199-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,7]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4199"],"URL":"https:\/\/doi.org\/10.1186\/s12935-026-04199-1","relation":{},"ISSN":["1475-2867"],"issn-type":[{"value":"1475-2867","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,7]]},"assertion":[{"value":"19 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article did not involve any clinical patient studies and, therefore, does not require an ethical statement. The authors are responsible for all aspects of the research, ensuring that any questions regarding the accuracy or integrity of any part of the work are addressed and resolved appropriately.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"124"}}